Phenotyping transgenic embryonic murine hearts using optical coherence tomography

Applied Optics

Volumn 46, Issue 10, 2007, Pages 1776-1781

  Jenkins, Michael W ^a   Patel, Pankti ^a   Deng, Huayun ^b   Montano, Monica M ^b   Watanabe, Michiko ^b   Rollins, Andrew M ^a  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; CARDIOLOGY; DATA ACQUISITION; PROTEINS;

CAVITY VOLUMES; DATA SETS; TRANSGENIC EMBRYONIC MURINE HEARTS; WALL THICKNESSES;

OPTICAL TOMOGRAPHY;

HEXIM1 PROTEIN, HUMAN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; GENETICS; HEART; HISTOLOGY; METHODOLOGY; MOUSE; MOUSE MUTANT; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PRENATAL DEVELOPMENT; TRANSGENIC MOUSE;

ANIMALS; HEART; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENOTYPE; RNA-BINDING PROTEINS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 34247491228     PISSN: 1559128X     EISSN: 15394522     Source Type: Journal    
DOI: 10.1364/AO.46.001776     Document Type: Conference Paper

References (17)

1. W. F. Dietrich, J. Miller, R. Steen, M. A. Merchant, D. DamronBoles, Z. Husain, R. Dredge, M. J. Daly, K. A. Ingalls, and T. J. O'Connor, "A comprehensive genetic map of the mouse genome," Nature 380, 149-152 (1996).
2. B. M. Wittmann, N. Wang, and M. M. Montano, "Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors," Cancer Res. 63, 5151-5158 (2003).
3. B. M. Wittmann, K. Fujinaga, H. Deng, N. Ogba, and M. M. Montano, "The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1," Oncogene 24, 5576-5588 (2005).
4. H. Deng, Y. Doughman, L. Chaplin, M. Watanabe, and M. M. Montano, "A critical role for HEXIM1 in heart development," FASEB J. 20:A1304-a (2006).
5. H. Deng, Y. Doughman, L. Chaplin, C. Padro, A. Koch, N. Wang, N. Ward, M. Watanabe, and M. M. Montano are preparing a paper to be called "Disruption of HEXIM1 gene: effects on heart and vascular development."
6. D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, C. A. Puliafito, and J. G. Fujimoto, "Optical coherence tomography," Science 254, 1178-1181 (1991).
7. A. F. Fercher, W. Drexler, C. K. Hitzenberger, and T. Lasser, "Optical coherence tomography - principles and applications," Rep. Prog. Phys. 66, 1-239 (2003).
8. S. A. Boppart, G. J. Tearney, B. E. Bouma, J. F. Southern, M. E. Brezinski, and J. G. Fujimoto, "Noninvasive assessment of the developing Xenopus cardiovascular system using optical coherence tomograpy," Proc. Natl. Acad. Sci. U.S.A. 94, 4256-4261 (1997).
9. T. M. Yelbuz, M. A. Choma, L. Thrane, M. L. Kirby, and J. A. Izatt, "Optical coherence tomography a new high-resolution imaging technology to study cardiac development in chick embryos," Circulation 106, 2771-2774 (2002).
10. M. W. Jenkins, F. Rothenberg, D. Roy, Z. Hu, V. P. Nikolski, M. Watanabe, D. L. Wilson, I. R. Efimov, and A. M. Rollins, "4D embryonic cardiography using gated optical coherence tomography," Opt. Express 14, 736-748 (2006).
11. W. Luo, D. L. Marks, T. S. Ralston, and S. A. Boppart, "Three-dimensional optical coherence tomography of the embryonic murine cardiovascular system," J. Biomed. Opt. 11, 021014 (2006).
12. J. J. Pasquesi, S. C. Schlachter, M. D. Boppart, E. Chaney, S. J. Kaufman, and S. A. Boppart, "In vivo detection of exercise-induced ultrastructural changes in genetically-altered murine skeletal muscle using polarization-sensitive optical coherence tomography," Opt. Express 14, 1547-1556 (2006).
13. M. H. Kaufman, The Atlas of Mouse Development (Academic, 1998).
14. A. M. Rollins, S. Yazdanfar, M. Kulkarni, R. Ung-Arunyawee, and J. Izatt, "In vivo video rate optical coherence tomography," Opt. Express 3, 219-229 (1998).
15. Z. Hu and A. M. Rollins, "Quasi-telecentric optical design of a microscope-compatible OCT scanner," Opt. Express 13, 6407-6415 (2005).
16. P. Carmeliet, Y. S. Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, I. Cornelissen, E. Ehler, V. V. Kakkar, I. Stalmans, V. Mattot, J. C. Perriard, M. Dewerchin, W. Flameng, A. Nagy, E. Lupu, L. Moons, D. Collen, P. A. D'Amore, and D. T. Shima, "Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188," Nat. Med. 5, 495-502 (1999).
17. D. Abraham, R. Hofbauer, R. Schafer, R. Blumer, P. Paulus, A. Miksovsky, H. Traxler, A. Kocher, and S. Aharinejad, "Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy," Cire. Res. 87, 644-647 (2000).